173 related articles for article (PubMed ID: 18763219)
1. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
Roepke S; Merkl A; Dams A; Ziegenhorn A; Anghelescu IG; Heuser I; Lammers CH
Pharmacopsychiatry; 2008 Sep; 41(5):176-81. PubMed ID: 18763219
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates.
Dannlowski U; Baune BT; Böckermann I; Domschke K; Evers S; Arolt V; Hetzel G; Rothermundt M
Hum Psychopharmacol; 2008 Oct; 23(7):587-93. PubMed ID: 18663773
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
Konstantinidis A; Hrubos W; Nirnberger G; Windhager E; Lehofer M; Aschauer H; Kasper S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):242-7. PubMed ID: 16962224
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
[TBL] [Abstract][Full Text] [Related]
11. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
Villeneuve E; Lemelin S
J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
14. Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder.
Dom G; De Wilde B; Hulstijn W; van den Brink W; Sabbe B
Alcohol Alcohol; 2006; 41(4):412-20. PubMed ID: 16782972
[TBL] [Abstract][Full Text] [Related]
15. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression.
Todder D; Caliskan S; Baune BT
J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in patients with borderline personality disorder: an open-label trial.
Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
[TBL] [Abstract][Full Text] [Related]
18. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
Giménez-Roldán S; Navarro E; Mateo D
Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
[TBL] [Abstract][Full Text] [Related]
19. An open-label study of quetiapine in anorexia nervosa.
Bosanac P; Kurlender S; Norman T; Hallam K; Wesnes K; Manktelow T; Burrows G
Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935
[TBL] [Abstract][Full Text] [Related]
20. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
